This paper is in the following e-collection/theme issue:

Telehealth and Telemonitoring (1671) Sensors for Glucose Monitoring and Diabetes Management (33) Telemedicine for Diabetes (95)

Published on in Vol 22, No 8 (2020): August

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/21778, first published .
Glycemic Outcomes in Adults With Type 2 Diabetes Participating in a Continuous Glucose Monitor–Driven Virtual Diabetes Clinic: Prospective Trial

Glycemic Outcomes in Adults With Type 2 Diabetes Participating in a Continuous Glucose Monitor–Driven Virtual Diabetes Clinic: Prospective Trial

Glycemic Outcomes in Adults With Type 2 Diabetes Participating in a Continuous Glucose Monitor–Driven Virtual Diabetes Clinic: Prospective Trial

Authors of this article:

Amit R Majithia1 Author Orcid Image ;   Coco M Kusiak2 Author Orcid Image ;   Amy Armento Lee2 Author Orcid Image ;   Francis R Colangelo3 Author Orcid Image ;   Robert J Romanelli4 Author Orcid Image ;   Scott Robertson2 Author Orcid Image ;   David P Miller2 Author Orcid Image ;   David M Erani5 Author Orcid Image ;   Jennifer E Layne6 Author Orcid Image ;   Ronald F Dixon6 Author Orcid Image ;   Howard Zisser2 Author Orcid Image
Article Authors Cited by (37) Tweetations (12) Metrics

Journals

  1. Edelman S, Cavaiola T, Boeder S, Pettus J. Utilizing continuous glucose monitoring in primary care practice: What the numbers mean. Primary Care Diabetes 2021;15(2):199 View
  2. Galindo R, Parkin C, Aleppo G, Carlson A, Kruger D, Levy C, Umpierrez G, McGill J. What's Wrong with This Picture? A Critical Review of Current Centers for Medicare & Medicaid Services Coverage Criteria for Continuous Glucose Monitoring. Diabetes Technology & Therapeutics 2021;23(9):652 View
  3. Jackson M, Ahmann A, Shah V. Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring. Diabetes Technology & Therapeutics 2021;23(S1):S-27 View
  4. Ang I, Tan K, Tan C, Tan C, Kwek J, Tay J, Toh S. A Personalized Mobile Health Program for Type 2 Diabetes During the COVID-19 Pandemic: Single-Group Pre–Post Study. JMIR Diabetes 2021;6(3):e25820 View
  5. Kruger D, Anderson J. Continuous Glucose Monitoring (CGM) Is a Tool, Not a Reward: Unjustified Insurance Coverage Criteria Limit Access to CGM. Diabetes Technology & Therapeutics 2021;23(S3):S-45 View
  6. Gavin J, Bailey C. Real-World Studies Support Use of Continuous Glucose Monitoring in Type 1 and Type 2 Diabetes Independently of Treatment Regimen. Diabetes Technology & Therapeutics 2021;23(S3):S-19 View
  7. Verma R, Bhardwaj S, Lathia T, Kalra S, Ranadive R, Tanna S, Padsalge M, Juneja A, Samundra K, Thakkar P, Jain V, Kini V, Kothari S, Guntur S, Joshi S, Singal A. Personalized glycemic response led digital therapeutics program improves time in range in a period of 14 days. International Journal of Diabetes in Developing Countries 2023;43(3):425 View
  8. Hirsch I, Miller E. Integrating Continuous Glucose Monitoring Into Clinical Practices and Patients' Lives. Diabetes Technology & Therapeutics 2021;23(S3):S-72 View
  9. Kompala T, Wong J, Neinstein A. Diabetes Specialists Value Continuous Glucose Monitoring Despite Challenges in Prescribing and Data Review Process. Journal of Diabetes Science and Technology 2023;17(5):1265 View
  10. Vrany E, Hill-Briggs F, Ephraim P, Myers A, Garnica P, Fitzpatrick S. Continuous glucose monitors and virtual care in high-risk, racial and ethnic minority populations: Toward promoting health equity. Frontiers in Endocrinology 2023;14 View
  11. Chawla R, Jaggi S, Gupta A, Bantwal G, Patil S. Clinical Utility of a Digital Therapeutic Intervention in Indian Patients With Type 2 Diabetes Mellitus: 12-Week Prospective Single-Arm Intervention Study. JMIR Diabetes 2022;7(4):e41401 View
  12. Norman G, Paudel M, Parkin C, Bancroft T, Lynch P. Association Between Real-Time Continuous Glucose Monitor Use and Diabetes-Related Medical Costs for Patients with Type 2 Diabetes. Diabetes Technology & Therapeutics 2022;24(7):520 View
  13. Sharma V, Feldman M, Sharma R. Telehealth Technologies in Diabetes Self-management and Education. Journal of Diabetes Science and Technology 2024;18(1):148 View
  14. Joshi S, Verma R, Lathia T, Selvan C, Tanna S, Saraf A, Tiwaskar M, Modi A, Kalra S, K V, Chitale M, Malde F, Abdul Khader M, Singal A. Fitterfly Diabetes CGM Digital Therapeutics Program for Glycemic Control and Weight Management in People With Type 2 Diabetes Mellitus: Real-world Effectiveness Evaluation. JMIR Diabetes 2023;8:e43292 View
  15. Morris T, Aspinal F, Ledger J, Li K, Gomes M. The Impact of Digital Health Interventions for the Management of Type 2 Diabetes on Health and Social Care Utilisation and Costs: A Systematic Review. PharmacoEconomics - Open 2023;7(2):163 View
  16. Thomas A, Haak T, Tombek A, Kulzer B, Ehrmann D, Kordonouri O, Kroeger J, Schubert-Olesen O, Kolassa R, Siegmund T, Haller N, Heinemann L. Expertenaustausch zum Einsatz von kontinuierlichem Glukosemonitoring (CGM) im Diabetesmanagement: Eine aktuelle Bestandsaufnahme und Blick in die Zukunft. Diabetologie und Stoffwechsel 2023;18(01):57 View
  17. Schubert T, Clegg K, Karalis D, Desai N, Marrs J, McNeal C, Mintz G, Romagnoli K, Jones L. Impact of telehealth on the current and future practice of lipidology: a scoping review. Journal of Clinical Lipidology 2023;17(1):40 View
  18. Oser T, Litchman M, Allen N, Kwan B, Fisher L, Jortberg B, Polonsky W, Oser S. Personal Continuous Glucose Monitoring Use Among Adults with Type 2 Diabetes: Clinical Efficacy and Economic Impacts. Current Diabetes Reports 2021;21(11) View
  19. Majithia A, Erani D, Kusiak C, Layne J, Lee A, Colangelo F, Romanelli R, Robertson S, Brown S, Dixon R, Zisser H. Medication Optimization Among People With Type 2 Diabetes Participating in a Continuous Glucose Monitoring–Driven Virtual Care Program: Prospective Study. JMIR Formative Research 2022;6(4):e31629 View
  20. Grace T, Salyer J. Use of Real-Time Continuous Glucose Monitoring Improves Glycemic Control and Other Clinical Outcomes in Type 2 Diabetes Patients Treated with Less Intensive Therapy. Diabetes Technology & Therapeutics 2022;24(1):26 View
  21. Cowart K, Updike W, Franks R. Continuous glucose monitoring in persons with type 2 diabetes not using insulin. Expert Review of Medical Devices 2021;18(11):1049 View
  22. Barnard-Kelly K, Parkin C. Health-Care Disparities in the Use of Diabetes Technologies in the UK. International Journal of Diabetes and Technology 2022;1(2):56 View
  23. Peahl A, Turrentine M, Srinivas S, King T, Zahn C. Routine Prenatal Care. Obstetrics and Gynecology Clinics of North America 2023;50(3):439 View
  24. Aleppo G, Gal R, Raghinaru D, Kruger D, Beck R, Bergenstal R, Cushman T, Hood K, Johnson M, McArthur T, Bradshaw A, Olson B, Oser S, Oser T, Kollman C, Weinstock R. Comprehensive Telehealth Model to Support Diabetes Self-Management. JAMA Network Open 2023;6(10):e2336876 View
  25. Kumbara A, Iyer A, Green C, Jepson L, Leone K, Layne J, Shomali M. Impact of a Combined Continuous Glucose Monitoring–Digital Health Solution on Glucose Metrics and Self-Management Behavior for Adults With Type 2 Diabetes: Real-World, Observational Study. JMIR Diabetes 2023;8:e47638 View
  26. Reddy S, Wu C, José A, Hsieh J, Rautela S. Personalized Virtual Care Using Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Less Intensive Therapies. Clinical Diabetes 2023;41(3):452 View
  27. Sun R, Duan Y, Zhang Y, Feng L, Ding B, Yan R, Ma J, Su X. Time in Range Estimation in Patients with Type 2 Diabetes is Improved by Incorporating Fasting and Postprandial Glucose Levels. Diabetes Therapy 2023;14(8):1373 View
  28. Miller E, Polonsky W, Miller K. What Role Might There Be for Continuous Glucose Monitoring in the Assessment of Diabetes Risk?. Diabetes Technology & Therapeutics 2023;25(S3):S-14 View
  29. Wright E, Subramanian S. Is Continuous Glucose Monitoring a Tool, an Intervention, or Both?. Diabetes Technology & Therapeutics 2023;25(S3):S-48 View
  30. Aleppo G, Hirsch I, Parkin C, McGill J, Galindo R, Kruger D, Levy C, Forlenza G, Umpierrez G, Grunberger G, Bergenstal R. Coverage for Continuous Glucose Monitoring for Individuals with Type 2 Diabetes Treated with Nonintensive Therapies: An Evidence-Based Approach to Policymaking. Diabetes Technology & Therapeutics 2023;25(10):741 View
  31. Peyyety V, Zupa M, Hewitt B, Rodriguez Gonzalez A, Mani I, Prioleau T, McCurley J, Lin Y, Vajravelu M. Barriers and Facilitators to Uptake of Continuous Glucose Monitoring for Management of Type 2 Diabetes Mellitus in Youth. The Science of Diabetes Self-Management and Care 2023;49(6):426 View
  32. Kitazawa M, Takeda Y, Hatta M, Horikawa C, Sato T, Osawa T, Ishizawa M, Suzuki H, Matsubayashi Y, Fujihara K, Yamada T, Sone H. Lifestyle Intervention With Smartphone App and isCGM for People at High Risk of Type 2 Diabetes: Randomized Trial. The Journal of Clinical Endocrinology & Metabolism 2024;109(4):1060 View
  33. Pangrace M, Dolan S, Grace T, Greene E, Long E, McClelland S, Moore J, Morgan D, Mullins H, Wescott S. AMCP Market Insights Health Plan Best Practice: Implementing continuous glucose monitoring to improve patient outcomes in diabetes. Journal of Managed Care & Specialty Pharmacy 2024;30(1-a Suppl):S1 View
  34. Ajjan R, Battelino T, Cos X, Del Prato S, Philips J, Meyer L, Seufert J, Seidu S. Continuous glucose monitoring for the routine care of type 2 diabetes mellitus. Nature Reviews Endocrinology 2024;20(7):426 View
  35. Barnard‐Kelly K, Martínez‐Brocca M, Glatzer T, Oliver N. Identifying the deficiencies of currently available CGM to improve uptake and benefit. Diabetic Medicine 2024;41(8) View
  36. Galindo R, Aleppo G, Parkin C, Baidal D, Carlson A, Cengiz E, Forlenza G, Kruger D, Levy C, McGill J, Umpierrez G. Increase Access, Reduce Disparities: Recommendations for Modifying Medicaid CGM Coverage Eligibility Criteria. Journal of Diabetes Science and Technology 2024;18(4):974 View
  37. Williamson R, Powell R, Shepherd A. Improving Diabetic Care Through Education and Innovation. Journal of Doctoral Nursing Practice 2024;17(2):86 View